AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
PINAVERIUM
4 registrations across 3 African markets— 3 active
Markets with PINAVERIUM
Recent registrations
| Brand / Product | Market | Holder | Status | Expires |
|---|---|---|---|---|
| DICETEL 100 Comprimé pelliculé / 100 mg | 🇹🇳Tunisia | TERIAK | expired | Jun 2002 |
| DICETEL® 100MG CP PELL BTE (2X15) MYLAN MEDICAL SAS comprimé pelliculé 100mg | 🇲🇬Madagascar | MYLAN MEDICAL SAS 40-44 | active | — |
| DICETEL® 100MG CP PELL BTE (2X15) MYLAN MEDICAL SAS comprimé pelliculé 100mg | 🇲🇬Madagascar | MYLAN MEDICAL SAS 40-44 | active | — |
| DICETEL COMPRIME PELLICULE | 🇲🇦Morocco | — | active | — |
PINAVERIUM in Africa — Regulatory Overview
PINAVERIUM is registered across 3 African markets with 4 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Madagascar, Morocco, Tunisia. AfricaRegulatory refreshes this data daily from official government sources.
Of the 4 registrations, 3 (75%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.